Related Experiment Video
Updated: Feb 28, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1'- and 4'-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases
Simon M Walker1, Calvin J Gordon1, Egor P Tchesnokov1
1Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2E1, Canada.
Two nucleotide analogs, remdesivir and GS-7682, show anti-flavivirus activity by inhibiting viral RNA polymerase. Their active forms exhibit distinct inhibition mechanisms, with remdesivir generally proving superior against flaviviruses.
Area of Science:
- Virology
- Drug Discovery
- Biochemistry
Background:
- Flaviviruses are globally significant arthropod-borne RNA viruses causing human diseases.
- No direct-acting antivirals are currently approved for flavivirus infections.
- The RNA-dependent RNA polymerase (RdRp) is a key target for antiviral development.
Purpose of the Study:
- To determine the anti-flavivirus potency of remdesivir and GS-7682.
- To characterize the active triphosphate forms (GS-443902 and GS-646939) against various flavivirus RdRps.
- To elucidate the mechanisms of inhibition employed by these nucleotide analogs.
Main Methods:
- Enzyme kinetics assays were performed using purified flavivirus RdRps.
- Incorporation and inhibition of nucleotide analogs GS-443902 and GS-646939 were analyzed.
- Comparison of inhibition mechanisms: immediate chain termination vs. template-dependent inhibition.
Main Results:
- Both GS-443902 and GS-646939 were efficiently incorporated into viral RNA.
- GS-646939 acted as an immediate chain terminator.
- GS-443902 inhibited flavivirus RdRp by impeding UTP incorporation (template-dependent inhibition).
- Remdesivir (GS-443902) generally showed superior anti-flavivirus activity.
Conclusions:
- Nucleotide analogs exhibit anti-flavivirus activity through distinct mechanisms.
- Immediate chain termination is not always the most effective inhibition strategy.
- Template-dependent inhibition is a viable mechanism, particularly for viruses lacking proofreading.
- Further investigation into nucleotide analog mechanisms is warranted for drug development.
Related Concept Videos
Viruses with RNA Genomes
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Subviral Agents
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...

